-
Loading metrics
Netazepide, a Gastrin Receptor Antagonist, Normalises Tumour Biomarkers and Causes Regression of Type 1 Gastric Neuroendocrine Tumours in a Nonrandomised Trial of Patients with Chronic Atrophic Gastritis
- Andrew R. Moore,
- Malcolm Boyce,
- Islay A. Steele,
- Fiona Campbell,
- Andrea Varro,
- D. Mark Pritchard
x
- Published: October 1, 2013
- https://doi.org/10.1371/journal.pone.0076462